Cargando…

Loss of Yes-associated Protein Represents an Aggressive Subtype of Colorectal Cancer

Background: Yes-associated protein (YAP) is a downstream effecter of Hippo signaling pathway, and has been linked to the initiation and development of colorectal cancer (CRC). However, the clinical significance of YAP in CRC remains controversial. This study was designed to investigate the clinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Sheng, Wei, Qing, Yang, Yongzhi, Qin, Huanlong, Li, Xinxiang, Cai, Sanjun, Ma, Yanlei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360423/ https://www.ncbi.nlm.nih.gov/pubmed/30719167 http://dx.doi.org/10.7150/jca.28333

Ejemplares similares

Human oral microbiome dysbiosis as a novel non-invasive biomarker in detection of colorectal cancer
por: Zhang, Sheng, et al.
Publicado: (2020)

Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer
por: Yang, Yongzhi, et al.
Publicado: (2019)

c-Myb and its Effector COX-2 as an Indicator Associated with Prognosis and Therapeutic Outcome in Colorectal Cancer
por: Xie, Ruting, et al.
Publicado: (2019)

High expression of protein phosphatase 4 is associated with the aggressive malignant behavior of colorectal carcinoma
por: Li, Xinxiang, et al.
Publicado: (2015)

Long non-coding RNAs in Colorectal Cancer: Progression and Future Directions
por: Yang, Yongzhi, et al.
Publicado: (2017)

Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer
por: Zhang, Sheng, et al.
Publicado: (2019)

Circulating basophil count as a prognostic marker of tumor aggressiveness and survival outcomes in colorectal cancer
por: Liu, Qi, et al.
Publicado: (2020)

Obesity and Risk of Colorectal Cancer: A Systematic Review of Prospective Studies
por: Ma, Yanlei, et al.
Publicado: (2013)

Association between Fusobacterium nucleatum and colorectal cancer: Progress and future directions
por: Zhang, Sheng, et al.
Publicado: (2018)

Cyclin D1 G870A Polymorphism Contributes to Colorectal Cancer Susceptibility: Evidence from a Systematic Review of 22 Case-Control Studies
por: Yang, Yongzhi, et al.
Publicado: (2012)

miR-150 functions as a tumour suppressor in human colorectal cancer by targeting c-Myb
por: Feng, Junlan, et al.
Publicado: (2014)

N(6)-methyladenosine as a biological and clinical determinant in colorectal cancer: progression and future direction
por: Li, Jinming, et al.
Publicado: (2021)

FBW7 suppresses metastasis of colorectal cancer by inhibiting HIF1α/CEACAM5 functional axis
por: Li, Qingguo, et al.
Publicado: (2018)

The effect of perioperative probiotics treatment for colorectal cancer: short-term outcomes of a randomized controlled trial
por: Yang, Yongzhi, et al.
Publicado: (2016)

Adenocarcinoma with mixed subtypes is a rare but aggressive histologic subtype in colorectal cancer
por: Sheng, Hui, et al.
Publicado: (2019)

Dysbiosis of human gut microbiome in young-onset colorectal cancer
por: Yang, Yongzhi, et al.
Publicado: (2021)

Evaluating the Guiding Role of Elevated Pretreatment Serum Carcinoembryonic Antigen Levels for Adjuvant Chemotherapy in Stage IIA Colon Cancer: A Large Population-Based and Propensity Score-Matched Study
por: Liu, Qi, et al.
Publicado: (2019)

Dual roles of yes-associated protein (YAP) in colorectal cancer
por: Ou, Chunlin, et al.
Publicado: (2017)

Survival Benefit of Preoperative Versus Postoperative Radiotherapy in Metastatic Rectal Cancer Treated With Definitive Surgical Resection of Primary Tumor: A Population Based, Propensity Score-Matched Study
por: Luo, Dakui, et al.
Publicado: (2019)

The correlation between tumor size, lymph node status, distant metastases and mortality in rectal cancer patients without neoadjuvant therapy
por: Luo, Dakui, et al.
Publicado: (2021)

Proteomic profiling reveals a signature for optimizing prognostic prediction in Colon Cancer
por: Shan, Zezhi, et al.
Publicado: (2021)

PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism
por: Dai, Weixing, et al.
Publicado: (2022)

Systematic literature review and clinical validation of circulating microRNAs as diagnostic biomarkers for colorectal cancer
por: Pan, Cheng, et al.
Publicado: (2017)

Congenital nephrotic syndrome: is early aggressive treatment needed? Yes
por: Hölttä, Tuula, et al.
Publicado: (2020)

Depicting the landscape of gut microbial-metabolic interaction and microbial-host immune heterogeneity in deficient and proficient DNA mismatch repair colorectal cancers
por: Li, Jinming, et al.
Publicado: (2023)

A novel epithelial‐mesenchymal transition molecular signature predicts the oncological outcomes in colorectal cancer
por: Shan, Zezhi, et al.
Publicado: (2021)

The influence of marital status on stage at diagnosis and survival of patients with colorectal cancer
por: Li, Qingguo, et al.
Publicado: (2015)

HER2 status is positively associated with vessel invasion of colorectal cancer: a retrospective large cohort study
por: Wang, Mingdian, et al.
Publicado: (2022)

The preoperative SUVmax for (18)F-FDG uptake predicts survival in patients with colorectal cancer
por: Shi, Debing, et al.
Publicado: (2015)

Nomograms for predicting the prognostic value of serological tumor biomarkers in colorectal cancer patients after radical resection
por: Li, Qingguo, et al.
Publicado: (2017)

Yes-associated protein expression is associated with poor prognosis in patients with colorectal cancer
por: Cao, Liyu, et al.
Publicado: (2021)

Novel evidence for a PIWI-interacting RNA (piRNA) as an oncogenic mediator of disease progression, and a potential prognostic biomarker in colorectal cancer
por: Weng, Wenhao, et al.
Publicado: (2018)

Yes
por: Stanley, Arthur
Publicado: (1923)

Yes-associated protein at the intersection of liver cell fate determination
por: Bai, Yong-Feng, et al.
Publicado: (2019)

ACRNaCT trial protocol: efficacy of adjuvant chemotherapy in patients with clinical T3b/T4, N+ rectal Cancer undergoing Neoadjuvant Chemoradiotherapy: a pathology-oriented, prospective, multicenter, randomized, open-label, parallel group clinical trial
por: Li, Qingguo, et al.
Publicado: (2019)

Changes in Incidence and Survival by Decade of Patients With Primary Colorectal Lymphoma: A SEER Analysis
por: Li, Qingguo, et al.
Publicado: (2020)

Analysis of the Intestinal Lumen Microbiota in an Animal Model of Colorectal Cancer
por: Zhu, Qingchao, et al.
Publicado: (2014)

Deficiency of Yes-Associated Protein Induces Cataract in Mice
por: He, Qing, et al.
Publicado: (2019)

APC Mutation Marks an Aggressive Subtype of BRAF Mutant Colorectal Cancers
por: Fennell, Lochlan J., et al.
Publicado: (2020)

Prognosis of three histological subtypes of colorectal adenocarcinoma: A retrospective analysis of 8005 Chinese patients
por: Li, Chao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8nqmf4nbjeclhsk13i4nsalrmh